Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Chola Securities’ Dharmesh Kant bets on banks, power; cautions on consumer valuations
Dharmesh Kant, Head Research at Chola Securities, says India's growth outlook remains strong, driven by robust demand, infrastructure execution and healthy credit growth. He remains positive on power equipment after further correction, prefers select private and PSU banks, sees value in pharma and hospitals, and is constructive on Mumbai-focused real estate. However, he advises caution on richly valued consumer stocks despite improving business fundamentals.
Dividend alert! Last day to buy JSW Steel, Sun Pharma, 4 more stocks to earn payouts up to Rs 75
JSW Steel has fixed Tuesday as the record date for its final dividend of Rs 7.1 per share for the financial year 2026. Once approved by the shareholders during its upcoming Annual General Meeting (AGM), the said dividend will be paid within 30 days from the date of its declaration, the company said.
Stocks in news: HDFC Bank, Vedanta Power, YES Bank, Sun Pharma, Waaree Energies
Indian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank and YES Bank. Analysts note a technical breakout, though resistance looms. Several companies, including Dabur India and Vedanta Power, reported positive quarterly updates, while Tata Power withdrew a controversial distribution application. ONGC's leadership eligibility criteria have also been broadened.
Record Date Alert: 15 companies set to see corporate actions for dividend, bonus this week
More than 15 stocks, including multiple Nifty 50 constituents, such as Titan, Hindalco, JSW Steel, and Sun Pharma are set to see record dates for their respective corporate actions announced earlier, alongside their fourth quarter results. While most of these corporate actions pertain to final dividend announcements, some also include bonus issue awards as well.
Sun Pharma secures relief in 'Pantocid' trademark dispute
Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.
Barometers extend winning streak for 3rd session; Nifty settles above 24,250 mark
The Nifty settled above the 24,250 mark. Realty, IT and pharma shares advanced, while PSU bank, media and auto shares declined.
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
IBM to set up one of India's first quantum computers in Amaravati by September 2026
Amaravati is set to become a major hub for quantum computing in India, with IBM announcing plans to install one of its advanced quantum systems there by September 2026. This move, driven by India's strong talent pool, aims to unlock significant commercial advantages across various sectors. The initiative aligns with Andhra Pradesh's vision to establish itself as a leading quantum technology center, fostering research and innovation.
Elara Securities turns bullish on banks, power, IT after market correction
Bino Pathiparampil, Head of Research, Elara Securities (India), says Indian markets are nearing a medium-term bottom after a prolonged correction and is turning constructive on banks, power, select new-age companies, IT and real estate. While pharma remains a defensive bet, he expects margin pressure to limit near-term outperformance. He also believes IT stocks are gradually pricing in AI-led headwinds, making it a good time to start accumulating quality names.
Coal India to invest ₹1,900 crore in R&D by FY30
Coal India Ltd is set to invest nearly ₹1,900 crore in R&D by FY2030 to boost mine productivity and cut emissions. The company is focusing on cleaner coal technologies and alternative energy sources, with its R&D spending significantly increasing this fiscal. New initiatives include a National Centre for Coal and Energy Research and collaborations with international partners for advanced projects.
Nifty 50 index slides below 23,950 level; auto shares outperform as Maruti Suzuki leads charge
The key equity benchmarks continued to trade below the flat line in afternoon trade. The Nifty 50 index traded below the 23,950 level. Auto, pharma and realty index advanced while IT, banks and FMCG stocks declined.